antibiotic resistance of karan only .pptx

litziya7894 21 views 51 slides Sep 18, 2024
Slide 1
Slide 1 of 51
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51

About This Presentation

Antibiotic Resistance


Slide Content

Antimicrobial Drugs Prof Dr Thamer Mutlag Jasim

Ehrlich’s Magic Bullets

Fleming and Penicillin

Chemotherapy The use of drugs to treat a disease Selective toxicity : A drug that kills harmful microbes without damaging the host

Antibiotic/Antimicrobial Antibiotic : Chemical produced by a microorganism that kills or inhibits the growth of another microorganism Antimicrobial agent : Chemical that kills or inhibits the growth of microorganisms

Microbial Sources of Antibiotics

Antibiotic Spectrum of Activity No antibiotic is effective against all microbes

Mechanisms of Antimicrobial Action Bacteria have their own enzymes for Cell wall formation Protein synthesis DNA replication RNA synthesis Synthesis of essential metabolites

Mechanisms of Antimicrobial Action Viruses use host enzymes inside host cells Fungi and protozoa have own eukaryotic enzymes The more similar the pathogen and host enzymes, the more side effects the antimicrobials will have

Modes of Antimicrobial Action

Penicillin (over 50 compounds) Share 4-sided ring ( b lactam ring) Natural penicillins Narrow range of action Susceptible to penicillinase ( b lactamase) Antibacterial Antibiotics Inhibitors of Cell Wall Synthesis

Prokaryotic Cell Walls

Penicillins Fig 20.6 Figure 20.6

Penicillinase ( b Lactamase) Figure 20.8

Penicilinase-resistant penicillins Carbapenems: very broad spectrum Monobactam: Gram negative Extended-spectrum penicillins Penicillins +  -lactamase inhibitors Semisynthetic Penicillins

Cephalosporins 2 nd , 3 rd , and 4 th generations more effective against gram-negatives Other Inhibitors of Cell Wall Synthesis Figure 20.9

Polypeptide antibiotics Bacitracin Topical application Against gram-positives Vancomycin Glycopeptide Important "last line" against antibiotic resistant S. aureus Other Inhibitors of Cell Wall Synthesis

Other Inhibitors of Cell Wall Synthesis Antibiotics effective against Mycobacteria: interfere with mycolic acid synthesis or incorporation Isoniazid (INH) Ethambutol

Broad spectrum, toxicity problems Examples Chloramphenicol (bone marrow) Aminoglycosides: Streptomycin, neomycin, gentamycin (hearing, kidneys) Tetracyclines (Rickettsias & Chlamydia; GI tract) Macrolides: Erythromycin (gram +, used in children) Inhibitors of Protein Synthesis

Polymyxin B (Gram negatives) Topical Combined with bacitracin and neomycin (broad spectrum) in over-the-counter preparation Injury to the Plasma Membrane

Rifamycin Inhibits RNA synthesis Antituberculosis Quinolones and fluoroquinolones Ciprofloxacin Inhibits DNA gyrase Urinary tract infections Inhibitors of Nucleic Acid Synthesis

Sulfonamides (Sulfa drugs) Inhibit folic acid synthesis Broad spectrum Competitive Inhibitors Figure 5.7

Antifungal Drugs Fungi are eukaryotes Have unique sterols in their cell walls Pathogenic fungi are often outside the body

Antiviral Drugs Viruses are composed of nucleic acid, protein capsid, and host membrane containing virus proteins Viruses live inside host cells and use many host enzymes Some viruses have unique enzymes for DNA/RNA synthesis or protein cutting in virus assembly Figure 20.16a

Antiviral Drugs Nucleoside and Nucleotide Analogs Figure 20.16a

Figure 20.16b, c Analogs Block DNA Synthesis

Inhibit assembly Indinavir (HIV) Inhibit attachment Zanamivir (Influenza) Inhibit uncoating Amantadine (Influenza) Antiviral Drugs Enzyme Inhibitors

Interferons prevent spread of viruses to new cells (Viral hepatitis) Natural products of the immune system in viral infections Antiviral Drugs Enzyme Inhibitors

Antiprotozoan Drugs Protozoa are eukaryotic cells Many drugs are experimental and their mode of action is unknown

Antihelminthic Drugs Helminths are macroscopic multicellular eukaryotic organisms: tapeworms, roundworms, pinworms, hookworms

Prevent ATP generation (Tapeworms) Alters membrane permeability (Flatworms) Neuromuscular block (Intestinal roundworms) Inhibits nutrient absorption (Intestinal roundworms) Paralyzes worm (Intestinal roundworms) Antihelminthic Drugs

Measuring Antimicrobial Sensitivity E Test MIC: Minimal inhibitory concentration

Measuring Antimicrobial Sensitivity: Disk Diffusion

Figure 20.20 Antibiotic Resistance

Antimicrobial Resistance Relative or complete lack of effect of antimicrobial against a previously susceptible microbe Increase in MIC

Enzymatic destruction of drug Prevention of penetration of drug Alteration of antibiotic or target site Rapid ejection of the drug Mechanisms of Antibiotic Resistance

Antibiotic Selection for Resistant Bacteria

What Factors Promote Antimicrobial Resistance? Exposure to sub-optimal levels of antimicrobial Exposure to microbes carrying resistance genes

Inappropriate Antimicrobial Use Prescription not taken correctly Antibiotics for viral infections Antibiotics sold without medical supervision Spread of resistant microbes in hospitals due to lack of hygiene

Inappropriate Antimicrobial Use Lack of quality control in manufacture or outdated antimicrobial Inadequate surveillance or defective susceptibility assays Poverty or war Use of antibiotics in foods

Antibiotics in Foods Antibiotics are used in animal feeds and sprayed on plants to prevent infection and promote growth Multi drug-resistant Salmonella typhi has been found in 4 states in 18 people who ate beef fed antibiotics

Consequences of Antimicrobial Resistance Infections resistant to available antibiotics Increased cost of treatment

Multi-Drug Resistant TB

MRSA “mer-sah” Methicillin-Resistant Staphylococcus aureus Most frequent nosocomial (hospital-acquired) pathogen Usually resistant to several other antibiotics

Vancomycin Resistant Enterococci

Vancomycin Use USA

Proposals to Combat Antimicrobial Resistance Speed development of new antibiotics Track resistance data nationwide Restrict antimicrobial use Direct observed dosing (TB)

Proposals to Combat Antimicrobial Resistance Use more narrow spectrum antibiotics Use antimicrobial cocktails

Antimicrobial peptides Broad spectrum antibiotics from plants and animals Squalamine (sharks) Protegrin (pigs) Magainin (frogs) The Future of Chemotherapeutic Agents

Antisense agents Complementary DNA or peptide nucleic acids that binds to a pathogen's virulence gene(s) and prevents transcription The Future of Chemotherapeutic Agents
Tags